Moderna | COVID-19
Moderna studies two booster candidates to anticipate new variant-like mutations
Washington/UNI/Sputnik: American pharma company Moderna said on Friday it is studying two booster candidates designed to anticipate mutations similar to the Omicron COVID-19 variant discovered in South Africa this week.
"Moderna is already studying two multi-valent booster candidates in the clinic that were designed to anticipate mutations such as those that have emerged in the Omicron variant," the company said in a statement.
The new variant-B.1.1.52-was first detected in southern Africa.
This mutant variant has led to a surge in infections in South Africa and other countries in the southern part of the continent.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
